发布求助
文献互助 智能选刊 最新文献

Oncology Times最新文献

筛选
英文 中文
Ibrutinib + Venetoclax Extends PFS in Advanced Mantle Cell Lymphoma 伊布替尼+ Venetoclax可延长晚期套细胞淋巴瘤的生存期
Oncology Times Pub Date : 2024-05-01 DOI: 10.1097/01.cot.0001017112.79137.7f
M. Fuerst
{"title":"Ibrutinib + Venetoclax Extends PFS in Advanced Mantle Cell Lymphoma","authors":"M. Fuerst","doi":"10.1097/01.cot.0001017112.79137.7f","DOIUrl":"https://doi.org/10.1097/01.cot.0001017112.79137.7f","url":null,"abstract":"","PeriodicalId":19516,"journal":{"name":"Oncology Times","volume":"528 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141028199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shop Talk 店谈
Oncology Times Pub Date : 2024-05-01 DOI: 10.1097/01.cot.0001017128.07056.c1
{"title":"Shop Talk","authors":"","doi":"10.1097/01.cot.0001017128.07056.c1","DOIUrl":"https://doi.org/10.1097/01.cot.0001017128.07056.c1","url":null,"abstract":"","PeriodicalId":19516,"journal":{"name":"Oncology Times","volume":"60 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141035436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overcoming Resistance in Acute Myeloid Leukemia & Kidney Cancer 克服急性髓性白血病和肾癌的抗药性
Oncology Times Pub Date : 2024-05-01 DOI: 10.1097/01.cot.0001017076.86036.89
Chuck Holt
{"title":"Overcoming Resistance in Acute Myeloid Leukemia & Kidney Cancer","authors":"Chuck Holt","doi":"10.1097/01.cot.0001017076.86036.89","DOIUrl":"https://doi.org/10.1097/01.cot.0001017076.86036.89","url":null,"abstract":"","PeriodicalId":19516,"journal":{"name":"Oncology Times","volume":"62 1‐2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141045942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Durvalumab + Ceralasertib Treatment in Immunotherapy-Resistant Lung Cancer 免疫疗法耐药肺癌的 Durvalumab + Ceralasertib 治疗
Oncology Times Pub Date : 2024-05-01 DOI: 10.1097/01.cot.0001017084.63519.4b
Catlin Nalley
{"title":"Durvalumab + Ceralasertib Treatment in Immunotherapy-Resistant Lung Cancer","authors":"Catlin Nalley","doi":"10.1097/01.cot.0001017084.63519.4b","DOIUrl":"https://doi.org/10.1097/01.cot.0001017084.63519.4b","url":null,"abstract":"","PeriodicalId":19516,"journal":{"name":"Oncology Times","volume":"161 s336","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141040706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Study Shows Impact of CAR-NK Cells on B-Cell Tumor Treatment 新研究显示 CAR-NK 细胞对 B 细胞肿瘤治疗的影响
Oncology Times Pub Date : 2024-05-01 DOI: 10.1097/01.cot.0001017044.21768.4a
L. Nolen
{"title":"New Study Shows Impact of CAR-NK Cells on B-Cell Tumor Treatment","authors":"L. Nolen","doi":"10.1097/01.cot.0001017044.21768.4a","DOIUrl":"https://doi.org/10.1097/01.cot.0001017044.21768.4a","url":null,"abstract":"","PeriodicalId":19516,"journal":{"name":"Oncology Times","volume":"171 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141050198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights Into Temozolomide Resistance in Glioblastoma 对胶质母细胞瘤中替莫唑胺耐药性的认识
Oncology Times Pub Date : 2024-05-01 DOI: 10.1097/01.cot.0001017120.47169.4e
Dibash Kumar Das
{"title":"Insights Into Temozolomide Resistance in Glioblastoma","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001017120.47169.4e","DOIUrl":"https://doi.org/10.1097/01.cot.0001017120.47169.4e","url":null,"abstract":"","PeriodicalId":19516,"journal":{"name":"Oncology Times","volume":"8 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141055783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AI-Based Smart Phone App Helps Physicians Make Melanoma Diagnosis 基于人工智能的智能手机应用程序帮助医生诊断黑色素瘤
Oncology Times Pub Date : 2024-05-01 DOI: 10.1097/01.cot.0001017116.98557.0b
M. Fuerst
{"title":"AI-Based Smart Phone App Helps Physicians Make Melanoma Diagnosis","authors":"M. Fuerst","doi":"10.1097/01.cot.0001017116.98557.0b","DOIUrl":"https://doi.org/10.1097/01.cot.0001017116.98557.0b","url":null,"abstract":"","PeriodicalId":19516,"journal":{"name":"Oncology Times","volume":"29 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141041773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Belzutifan (Welireg®) 贝舒替凡 (Welireg®)
Oncology Times Pub Date : 2024-05-01 DOI: 10.1097/01.cot.0001017068.55209.61
Janelle E. Mann
{"title":"Belzutifan (Welireg®)","authors":"Janelle E. Mann","doi":"10.1097/01.cot.0001017068.55209.61","DOIUrl":"https://doi.org/10.1097/01.cot.0001017068.55209.61","url":null,"abstract":"","PeriodicalId":19516,"journal":{"name":"Oncology Times","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141024005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can Telemedicine Safely Replace In-Person Care for Cancer Patients? 远程医疗能否安全地取代癌症患者的亲自治疗？
Oncology Times Pub Date : 2024-05-01 DOI: 10.1097/01.cot.0001017080.70668.c6
Sarah DiGiulio
{"title":"Can Telemedicine Safely Replace In-Person Care for Cancer Patients?","authors":"Sarah DiGiulio","doi":"10.1097/01.cot.0001017080.70668.c6","DOIUrl":"https://doi.org/10.1097/01.cot.0001017080.70668.c6","url":null,"abstract":"","PeriodicalId":19516,"journal":{"name":"Oncology Times","volume":"25 15","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141037492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lifileucel Approval Signals Progress in Advanced Melanoma Treatment Lifileucel 获批标志着晚期黑色素瘤治疗取得进展
Oncology Times Pub Date : 2024-05-01 DOI: 10.1097/01.cot.0001017088.72742.82
Dibash Kumar Das
{"title":"Lifileucel Approval Signals Progress in Advanced Melanoma Treatment","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001017088.72742.82","DOIUrl":"https://doi.org/10.1097/01.cot.0001017088.72742.82","url":null,"abstract":"","PeriodicalId":19516,"journal":{"name":"Oncology Times","volume":"29 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141048811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信